These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24750373)

  • 1. Racial disparities in cardiovascular risk factor control in an underinsured population with Type 2 diabetes.
    Wang Y; Katzmarzyk PT; Horswell R; Zhao W; Li W; Johnson J; Ryan DH; Hu G
    Diabet Med; 2014 Oct; 31(10):1230-6. PubMed ID: 24750373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of intensive glucose lowering therapy among major racial/ethnic groups in the Veterans Affairs Diabetes Trial.
    Saremi A; Schwenke DC; Bahn G; Ge L; Emanuele N; Reaven PD;
    Metabolism; 2015 Feb; 64(2):218-25. PubMed ID: 25456099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
    Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
    Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study.
    Freedman BI; Hsu FC; Langefeld CD; Rich SS; Herrington DM; Carr JJ; Xu J; Bowden DW; Wagenknecht LE
    Diabetologia; 2005 Dec; 48(12):2511-8. PubMed ID: 16261310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Egg consumption and cardiovascular disease according to diabetic status: The PREDIMED study.
    Díez-Espino J; Basterra-Gortari FJ; Salas-Salvadó J; Buil-Cosiales P; Corella D; Schröder H; Estruch R; Ros E; Gómez-Gracia E; Arós F; Fiol M; Lapetra J; Serra-Majem L; Pintó X; Babio N; Quiles L; Fito M; Marti A; Toledo E;
    Clin Nutr; 2017 Aug; 36(4):1015-1021. PubMed ID: 27448949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of treatment response in patients with newly diagnosed type 2 diabetes: the Skaraborg diabetes register.
    Pikkemaat M; Melander O; Hjerpe P; Bengtsson Boström K
    J Diabetes Complications; 2017 May; 31(5):854-858. PubMed ID: 28319005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with Type 2 diabetes: results from a randomized controlled trial.
    Simpson SH; Lier DA; Majumdar SR; Tsuyuki RT; Lewanczuk RZ; Spooner R; Johnson JA
    Diabet Med; 2015 Jul; 32(7):899-906. PubMed ID: 25594919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes.
    Lafata JE; Karter AJ; O'Connor PJ; Morris H; Schmittdiel JA; Ratliff S; Newton KM; Raebel MA; Pathak RD; Thomas A; Butler MG; Reynolds K; Waitzfelder B; Steiner JF
    J Gen Intern Med; 2016 Feb; 31(2):188-195. PubMed ID: 26282954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HbA1c but not diabetes duration predicts increased arterial stiffness in adolescents with poorly controlled type 1 diabetes.
    Obermannova B; Petruzelkova L; Sulakova T; Sumnik Z
    Pediatr Diabetes; 2017 Jun; 18(4):304-310. PubMed ID: 27075550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparities in diabetic complications in an underinsured population.
    Wang Y; Katzmarzyk PT; Horswell R; Li W; Xiao K; Besse J; Xie W; Johnson J; Heymsfield S; Ryan DH; Hu G
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4446-53. PubMed ID: 22977274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential implications of the choice among three alternative treatment targets for apolipoprotein B100 in the management of patients with type 2 diabetes and chronic kidney disease.
    Boronat M; García-Cantón C; López-Ríos L; Quevedo V; Lorenzo DL; Batista F; Riaño M; Nóvoa FJ
    Diab Vasc Dis Res; 2014 Jan; 11(1):53-9. PubMed ID: 24254975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart matters: Gender and racial differences cardiovascular disease risk factor control among veterans.
    Goldstein KM; Melnyk SD; Zullig LL; Stechuchak KM; Oddone E; Bastian LA; Rakley S; Olsen MK; Bosworth HB
    Womens Health Issues; 2014; 24(5):477-83. PubMed ID: 25213741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of and Racial Disparities in Risk Factor Control in Older Adults With Diabetes: The Atherosclerosis Risk in Communities Study.
    Parrinello CM; Rastegar I; Godino JG; Miedema MD; Matsushita K; Selvin E
    Diabetes Care; 2015 Jul; 38(7):1290-8. PubMed ID: 25852205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
    Heller SR; Bergenstal RM; White WB; Kupfer S; Bakris GL; Cushman WC; Mehta CR; Nissen SE; Wilson CA; Zannad F; Liu Y; Gourlie NM; Cannon CP;
    Diabetes Obes Metab; 2017 May; 19(5):664-671. PubMed ID: 28058763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes.
    Laffin LJ; Bakris GL
    Diabetes Obes Metab; 2018 Jun; 20(6):1335-1336. PubMed ID: 29424470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and ethnic disparities in the control of cardiovascular disease risk factors in Southwest American veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study.
    Wendel CS; Shah JH; Duckworth WC; Hoffman RM; Mohler MJ; Murata GH
    BMC Health Serv Res; 2006 May; 6():58. PubMed ID: 16716235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Risk Factor Status in Hospitalized Patients With Type 2 Diabetes in China.
    Yang X; Liu Q; Fan Y; Ding L; Wang R; Hu G; Liu M
    Front Endocrinol (Lausanne); 2021; 12():664183. PubMed ID: 34367063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial/ethnic differences in control of cardiovascular risk factors among type 2 diabetes patients in an insured, ambulatory care population.
    Holland AT; Zhao B; Wong EC; Choi SE; Wong ND; Palaniappan LP
    J Diabetes Complications; 2013; 27(1):34-40. PubMed ID: 23062328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.